Form 4: Angiodynamics Executive Receives Stock Grant
Insider Transaction (Form 4)
Lawrence T Weiss, SVP, Chief Legal Officer of Angiodynamics Inc, reported multiple transactions in common stock on July 15, 2026.
Summary
- Grant/award: acquired 21,288 Common Stock on July 15, 2026; holds 112,618 after (Direct).
- Grant/award: acquired 21,288 Performance Right on July 15, 2026; holds 21,288 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Lawrence T Weiss — Officer (SVP, Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Common Stock | 21,288 | — | — | 112,618 |
| 2026-07-15 | Grant/award | Performance Right | 21,288 | — | — | 21,288 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (21,288 shares) |
| 2026-07-15 | Grant/award (21,288 shares) |
Keywords
insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, Lawrence T Weiss
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.